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Localization of insulin receptor-related receptor in the rat kidney.
Insulin receptor-related receptor (IRR), a member of the insulin receptor
family, is most abundantly expressed in the kidney. However, its endoge-
nous ligand and physiological roles are still unknown. To elucidate the
physiological role of IRR, an orphan receptor, in the kidney, we examined
the localization of IRR mRNA and its immunoreactivity in the rat kidney
by in situ hybridization and immunohistochemistry, respectively. IRR
mRNA was found to be exclusively localized in the cortical collecting duct.
The localization of IRR immunoreactivity was consistent with that of IRR
mRNA. Furthermore, IRR immunoreactivity was found to be localized on
the basolateral plasma membrane of the epithelial cells that were a minor
cell subpopulation (20 to 30%) of the duct. The present findings indicated
that IRR in the kidney was exclusively localized on the basolateral plasma
membrane of type B intercalated cells of the cortical collecting duct.
Insulin and insulin-like growth factor-I (IGF-I) are known to be
important regulators of metabolism and growth (such as glucose
metabolism and cell proliferation) [1, 2]. These effects are medi-
ated by their receptors, insulin receptor and IGF-I receptors.
They have similar primary structures with an extracellular cys-
teine-rich domain that has a ligand-binding domain (a subunit), a
single transmembrane domain and a cytoplasmic domain with
intrinsic tyrosine kinase activity ( subunit), and consist of a2f32
heterotetramers [3]. Insulin receptor-related receptor (IRR) is a
third member of the insulin receptor family [4]. IRR also has a
similar primary structure and is expected to consist of an a22
heterotetramer. Two truncated forms of IRR with the cysteine-
rich domain, but not the transmembrane and tyrosine kinase
domains, also exist [5]. However, peptides of the insulin family
including insulin, IGF-I, IGF-II and relaxin do not bind to IRR [6,
7]. Therefore, the endogenous ligand and physiological roles of
IRR are still unknown.
In contrast to the widespread expression of insulin receptor and
IGF-I receptor mRNAs, IRR mRNA is focally expressed in the
kidney, stomach, brain and sympathetic and sensory neurons
[8—12]. To elucidate the physiological roles of IRR, it is important
to examine the cellular localization of IRR in these tissues. IRR
mRNA in the stomach was clearly shown to be preferentially
expressed in the enterochromaffin-like cells of the oxyntic glands
of the fundic stomach by in situ hybridization [13, 14]. The
expression of IRR mRNA in the brain is highly restricted to the
forebrain and brainstem [11, 12, 15]. Most IRR mRNA in these
regions is coexpressed with mRNA for trkA, a high affinity
receptor for nerve growth factor, indicating that these receptors
might be functionally linked in the central nervous system [11, 15].
Furthermore, IRR mRNA in the forebrain is preferentially
expressed in cholinergic neurons [121. IRR mRNA in the kidney
is also preferentially in the distal tubule segments [10, 14].
However, the identification of the IRR-positive distal tubule
segments and the cellular localization of IRR in the kidney
remains to be elucidated. In the present study, we examined these
unresolved problems by in situ hybridization and immunohisto-
chemistry.
METHODS
Preparation of RNA probes
Rat IRR eDNA [1479 base pairs (bp)1, rat renal kallikrein
eDNA (767 bp) [16], and rat aquaporin 3 (AQP3 eDNA) (840 hp)
[17] were amplified from rat kidney poly(A) + RNA by reverse
transcription-polymerase chain reaction (RT-PCR) with the primers,
TCTGGAGGATACCTAGAA and CAGCACGATCTCCAYF-
GGTC, TGGACACCT'GATACCATGTG and GmGGTGTA-
GATGGTGGC, and AGATGCTCCAcATCCGCTAC and AG-
ATcTGGTCcITFGTGcTTC, respectively. These amplified cDNAs
were cloned into the pGEM-T vector DNA (Promega, Madison,
WI, USA). A 35S-labeled or digoxigenin-labeled RNA probe was
transcribed from the cloned eDNA with T7 RNA polymerase in
the presence of uridine 5'-a-[35S]thiotriphosphate (30 TBq/mmol,
Amersham) or il-digoxigenin-uridinc triphosphate (Boehringer
Mannheim), respectively. These RNA probes were shortened by
alkaline hydrolysis as described previously [12, 13].
Double in situ hybridization with 355-labeled RNA and
digoxigenin-labeled RNA probes
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The kidneys were removed from 7-week-old male Wistar rats
and frozen in powdered dry ice. The tissues were cut into sections
of 16 .rm thickness on a ciyostat and the sections were thaw-
mounted onto poly-L-lysine-coated glass slides, and stored at
80°C. Double in situ hybridization was performed as described
previously [12, 13].
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Preparation of an affinity-purified antibody against rat IRR
A cDNA encoding the carboxy-terminal 90 amino acids of rat
IRR f3 subunit was amplified by PCR with the primers CTAGAG-
GAGCAAGAGGATFG and TCAGTGTCCTGGGTCCCCAT,
and cloned into the pGEX-4T-1 DNA expression vector (Phar-
macia Biotech). The glutathione S-transferase (GST) fusion pro-
tein with the carboxy-terminal 90 amino acids of IRR 13 subunit
was expressed from the recombinant DNA in E. coli, and purified
using a Glutathione Sepharose 4B affinity column.
Rabbits were first immunized with the GST fusion protein in
Freund's complete adjuvant, followed by four booster injections
with the protein in Freund's incomplete adjuvant at two week
intervals. An anti-IRR antibody was purified from the rabbit
antiserum by affinity chromatograph on a column of the GST
fusion protein bound to Sepharose HP (HiTrap-NHS activated;
Pharmacia Biotech).
Western blotting
The kidney cortex was homogenized in 15 volume (vol/wt) of 50
mM Tris/Ci buffer, pH 7.4 containing 0.25 M sucrose, 0.1 mM
phenylmethylsulfonyl fluoride and 10 tg/ml aprotinin (Sigma).
The membrane fraction was prepared by centrifugation at 100,000
Xg for one hour at 4°C. Proteins in the membrane fraction were
separated by sodium dodecyl sulfate (SDS)-polyacrylamide gel
(8%) electrophoresis under reducing conditions and transferred
onto nitrocellulose membranes (Hybond-ECL, Amersham). The
membranes were then incubated with PBS containing 0.1%
Tween 20 and 5% nonfat dry milk. The membranes were incu-
bated for one hour at room temperature with the affinity purified
anti-IRR antibody diluted 1:250 in PBS containing 0.1% Tween
20 (PBS-T) in the absence or presence of the GST fusion protein
with the carboxy-terminal 90 amino acids of rat IRR /3subunit (5
g/ml). After washing in PBS-T, the membranes were treated for
one hour at room temperature with goat anti-rabbit immunoglob-
ulin G conjugated to horseradish peroxidase, 1:2,000 (Cappel).
Membranes were washed four times in PBS-T and reacted with
chemiluminescent horseradish peroxidase substrate (ECL, Amer-
sham). IRR immunoreactivity was visualized by exposure of the
membranes to X-ray film (RX Medical; Fuji Film Co., Tokyo,
Japan).
Immunohistochemistry
Rats were anesthetized, and then perfused via the ascending
aorta with PBS, followed by 0.1 M sodium phosphate, pH 7.0
containing 0.2% picric acid and 2% paraformaldehyde. After
perfusion, the kidneys were removed, placed in 0.1 M sodium
phosphate, pH 7.0, containing 30% sucrose for one day at 4°C and
frozen in powdered dry ice. Consecutive coronal sections were cut
at a thickness of 10 or 16 tm using a cryostat, and thaw-mounted
onto gelatin-coated slides, The sections were pretreated with PBS
containing 2% bovine serum albumin for one hour, and then
incubated overnight at 4°C with the affinity-purified anti-IRR
antibody diluted 1:400 in PBS containing 0.1% bovine serum
albumin and 0.1% Triton X-100. After washing in PBS three
times, the sections were incubated with a horseradish peroxidase-
conjugated goat anti-rabbit IgG antibody (Cappel) (1:500) over-
night at 4°C. After washed three times in PBS, the sections were
immersed in medium containing 50 mrvi Tris/HC1, pH 7.5 and
0.05% diaminobenzidine tetrahydrochloride (DAB) for 20 mm-
utes at 4°C. To visualize peroxidase labeling, the sections were
incubated in medium containing 50 mrvi Tris/HC1, pH 7.5, 0.05%
DAB and 0.01% hydrogen peroxide for two minutes at room
temperature. Adjacent sections were immunostained with the
anti-IRR antibody in the presence of the antigen, the GST fusion
protein with IRR (5 sg/ml), as controls.
RESULTS
Localization of IRR mRNA in the rat kidney
IRR mRNA in the kidney is preferentially expressed in the
distal tubule segments [10, 14]. The distal tubule is composed of
three segments, the distal convoluted tubule, connecting tubule
and cortical collecting duct [181. The distal convoluted tubule is
composed of a homogenous cell population of distal convoluted
tubule cells. In contrast, the connecting tubule is composed of a
heterogeneous cell population of connecting tubule cells and
intercalated cells. The cortical collecting duct is also composed of
a heterogeneous cell population of principal cells and intercalated
cells. We also examined the localization of IRR mRNA in the
kidney by in situ hybridization with a 35S-labeled IRR RNA probe.
Labeling was preferentially observed in the tubule segments
localized in the kidney cortex. IRR mRNA-positive cells were a
minor (20 to 30%) subpopulation of epithelial cells of the
IRR-positive tubule segments (data not shown). Therefore, the
IRR mRNA-positive tubular segments appeared to be the con-
necting tubule and/or cortical collecting duct.
To identify the IRR mRNA-positive tubule segments, sections
of the kidney were analyzed by double in situ hybridization with a
digoxigenin-labeled IRR RNA probe and a 35S-labeled RNA
probe for renal kallikrein mRNA, a specific marker for connecting
tubule cells of the connecting tubule [16] or a 35S-labeled RNA
probe for aquaporin 3 mRNA, a specific marker for principal cells
of the collecting duct (Fig. 1) [17]. Darkly stained cells show those
that expressed IRR mRNA, and black grains show the localization
of renal kallikrein or aquaporin 3 mRNA. Darkly stained, IRR
mRNA-positive, cells were a minor (20 to 30%) subpopulation of
epithelial cells of the IRR-positive tubule segments. IRR mRNA-
positive tubule segments did not express renal kallikrein mRNA
(Fig. 1A). Furthermore, renal kallikrein mRNA-positive tubule
segments did not express IRR mRNA (Fig. 1B). Thus, IRR
mRNA and renal kallikrein mRNA were not colocalized in the
tubule segments, indicating that the IRR mRNA-positive tubule
segment was not the connecting tubule. In contrast, IRR mRNA
and aquaporin 3 mRNA were colocalized in the tubule segments,
indicating that the IRR mRNA-positive tubule segment was the
cortical collecting duct (Fig. 1C). However, most IRR mRNA and
aquaporin 3 mRNA were not colocalized at the cellular level in
these segments (Fig. 1C).
Localization of IRR immunoreactivity in the kidney
To detect IRR protein in the kidney, we prepared an affinity-
purified antibody (anti-IRR antibody) against the intracellular
carboxy-terminal 90 amino acids of rat IRR /3 subunit. To identify
IRR immunoreactivity in the kidney cortex, the membrane fraction
of the kidney cortex was analyzed by Western blotting with the
anti-IRR antibody. A single IRR-immunoreactive band of 68 kDa
was detected (Fig. 2A). The immunoreactivity was diminished by
the antigen, the glutathione S-transferase (GST) fusion protein

















Fig. 2. Identification of IRR immunoreactivity in the rat kidney. The
membrane fraction of the kidney cortex was analyzed by Western blotting
with an affinity-purified anti-IRR antibody in the absence A) or presence
(B) of the antigen, the GST fusion protein with carboxy-terminal 90 amino
acids of IRR subunit (5 jzg/ml). Molecular masses (kDa) of standard
proteins are indicated on the left-hand side.
cortex but not the medulla (Fig. 3A). The immunoreactivity was
diminished by the antigen (Fig. 3B). IRR immunoreactivity was
observed in a minor subpopulation (20 to 30%) of epithelial cells
of these segments (Fig. 4A). These results are essentially consis-
tent with those by in situ hybridization. Furthermore, IRR immu-
noreactivity was found to be predominantly localized on the
basolateral plasma membrane of epithelial cells (Fig. 4B).
DISCUSSION
Fig. 1. Localization of IRR mRNA, renal kallikrein mRNA and aqua-
porin 3 mRNA in the rat kidney. Sections of the kidney (16 sm) were
examined by double in situ hybridization with digoxigcnin-lahclcd TRR
and 35S-laheled renal kallikrein RNA probes (A and B). Darkly stained
cells indicated by arrows show those that expressed IRR mRNA (A), and
black grains indicated by arrowheads show the localization of renal
kallikrein mRNA (B). Sections of the kidney were also examined by
double in situ hybridization with digoxigenin-laheled IRR and 35S-laheled
aquaporin 3 RNA probes (C). Darkly stained cells indicated by arrows
show those that expressed IRR mRNA, and black grains indicated by
arrowheads show the localization of aquaporin 3 mRNA. Scale bar = 50 m.
Sections of the rat kidney were analyzed by immunohistochem-
istly with the affinity-purified anti-IRR antibody. IRR immunore-
activity was observed in the tubule segments localized in the
ERR was found to be preferentially expressed in the distal
tubule segments [10, 14]. The distal tubule is composed of three
segments, the distal convoluted tubule, connecting tubule and
cortical collecting tubule [18—231. Reinhardt et al speculated that
the IRR mRNA-positive distal tubule segment was the connecting
tubule [10]. However, the IRR mRNA-positive distal tubule
segments were several millimeters in length, although the rat
connecting tubules are only 150 to 200 m in length [24].
Therefore, identification of the IRR mRNA-positive distal tubule
segment remains to be elucidated. The present study demon-
strated that ERR mRNA and aquaporin 3 mRNA, a specific
marker for principal cells of the collecting duct, were colocalized
in the cortical tubule segments, indicating that the IRR mRNA-
positive tubule segment was the cortical collecting duct.
The cortical collecting duct is composed of three types of
epithelial cells, principal cells and type A and type B intercalated
cells [181. Although principal cells are the major (—60%) sub-
population of epithelial cells in the cortical collecting duct, type A
and type B intercalated cells are minor (—20% each) subpopula-
tions [181. IRR mRNA-positive cells were a minor (20 to 30%)
subpopulation of epithelial cells in the cortical collecting duct.
Furthermore, IRR mRNA was not coexpressed with aquaporin 3
mRNA, a specific marker for principal cells, at the cellular level in
the cortical collecting duct. These results indicated that ERR
mRNA-positive cells were intercalated cells hut not principal
cells.
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Fig. 3. Localization of IRR immunoreactivity in the rat kidney. Sections
of the kidney (16 j.rm) were analyzed by immunohistochemistry with the
anti-IRR antibody in the absence 1A) or presence (B) of the antigen (5
tgfml). Scale bar = 250 rm.
Intercalated cells are expected to be involved in urine acidifi-
cation in the collecting duct. Type A and type B intercalated cells
are believed to be involved in H secretion and HC01 secretion,
respectively [18]. It has also been suggested that the type A and
type B configurations of intercalated cells could represent differ-
ent functional states of the same cell population, which would
change its polarity in response to changes in acid-base status of
the animal. Each of these two types (A and B) constitutes
approximately 50% of intercalated cells in the cortical collecting
tubule. Although type A intercalated cells exist both in the
connecting tubule and cortical collecting tubule, type B interca-
lated cells preferentially exist in the cortical collecting tubule [181.
Therefore, IRR mRNA-positive epithelial cells were expected to
be type B intercalated cells of the cortical collecting duct.
In Situ hybridization shows the localization of cells which
produce the mRNA of interest. In contrast, immunohistochemis-
try provides confirmation that the mRNA of interest is translated
and supplies important information about the subcellular local-
ization of the protein. We prepared an affinity-purified antibody
against the carboxy-terminal 90 amino acids of the rat IRR 13
subunit, and the anti-IRR antibody specifically recognized a
Fig. 4. Cellular localization of IRR immunoreactivity in rat cortical
tubule segments. The thin sections (10 jLm) of the kidney cortex was
analyzed by immunohistochemistry with the anti-IRR antibody at lower
A) and higher magnification (B). The arrow indicates a branching
structure of the cortical tubule segment. Scale bars = 50 sm (A) and 25
.rm (B).
protein of 68 kDa in the kidney. Jui et al reported that the
molecular mass of human IRR psubunit, which was exogenously
expressed in NIH 3T3 cells, was 66 kDa [191. Kovacina and Roth
also reported that the molecular mass of human IRR 13 subunit
from both neuroblastomas and IMR-5 cells was 66 kDa [20]. IRR
irnmunoreactivity in the kidney examined by immunohistochem-
istry was preferentially localized in a minor subpopulalion (20 to
30%) of epithelial cells of the cortical tubule segments. The
localization of IRR immunoreactivity was essentially consistent
with that of IRR mRNA by in situ hybridization. Therefore, the
anti-IRR antibody was expected to specifically recognize rat IRR
13 subunit of 68 kDa in the kidney.
The present study demonstrated that IRR was exclusively
localized on the basolateral plasma membrane of epithclial cells.
The kidney is a target organ for a number of polypeptide growth
factors [21]. These growth factors are thought to mediate adap-
tations in renal functions that occur in chronic reduction of
functional renal mass and to promote regeneration following
acute renal injury. Some growth factor receptors (such as IGF-l
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receptor and epidermal growth factor receptor) in the kidney are
also localized at the basotateral plasma membranes but not at the
apical membranes of tubule cells [22, 23]. Several growth factors
(such as IGF-I, epidermal growth factor, transforming growth
factor-/3, platelet-derived growth factor, fibroblast growth factor
and hepatocyte growth factor) are produced in the kidney, and
exert their effects on target cells in an autocrine or paracrine
fashion [21]. Therefore, although the endogenous ligand of IRR
remains to be elucidated, the endogenous ligand of IRR might
also be produced in the kidney.
By both in situ hybridization and immunohistochemistry, the
present study indicated that IRR in the kidney was exclusively
localized on the basolateral plasma membranes of type B inter-
calated cells of the cortical collecting duct. Although the endog-
enous ligand of IRR remains to be elucidated, IRR in the kidney
might specifically modulate the function, of intercalated cells. The
present findings will be useful for future studies to elucidate the
physiological significance of IRR and its ligand in the kidney.
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